Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
disorders
By
AbdAlAziz AbdAllah,
MD
Mineralocorticoid excess
I- 1ry hyper-aldosteronism (Conn
:syndrome)
Conn syndrome is characterized by increased
aldosterone secretion from the adrenal glands, it
was first described in 1955 by J. W. Conn in a
patient who had an aldosterone-producing
.adenoma
Pathophysiology
Primary hyperaldosteronism is caused by
increased aldosterone excretion from the
adrenals, which results primarily from 2 major
: subtypes
unilateral aldosterone-producing adenoma ,( 1)
Conn syndrome, (50-60% of cases)
:Frequency
Prevalence for Conn syndrome; 0.05-2% of the
.population
:Mortality/Morbidity
The morbidity and mortality associated with Conn
; syndrome, are primarily related to
Hypertension, especially if left untreated for- 1
many years, can lead to many complications,
including heart disease )eg, coronary artery
disease, congestive heart failure(, stroke, and
intracerebral hemorrhage )with very high blood
.pressure(
Clinical manifestations
; Hypertension;Hypokalemia-
; Metabolic alkalosis-
will lower ionized calcium levels and can
.cause tetany
:Investigations
Laboratory Studies
hypernatremia-
Hypokalemia; normokalemia does not-
exclude primary hyperaldosteronism. Several
studies have shown that 7-38% of patients
with primary hyperaldosteronism have
normal baseline serum levels of potassium
metabolic alkalosis-
Renin levels are suppressed to less than 1-
ng/mL/h in patients with primary
.hyperaldosteronism
A 24-hour aldosterone excretion rate of-
greater than 14 ug is diagnostic of primary
hyperaldosteronism
Imaging Studies
CT scanning-
MRI-
Treatment
Medical
medical therapy is used preoperatively to
prevent the morbidity and mortality associated
with hypertension and hypokalemia, thus
.decreasing surgical risk
Sodium-restricted diet )<80 mEq or <2 g of -
.sodium per day
Potassium-sparing agent )first-step agent( such-
as spironolactone100 mg initially, increase to
.400 mg/d for control of blood pressure
Surgical Care
Surgery is the main therapy for Conn
syndrome. A laparoscopic adrenalectomy
is favored, when possible
Anesthetic considerations
Preoperative correction of hypertension, CHF
and volume and electrolytes imbalance specially
.potassium is mandatory
Mineralocorticoid deficiency
Hypo-aldosteronism-
Atrophy or destruction of both adrenal
glands results in a combined deficiency of
Mineralocorticoid and glucocorticoid
.( addison disease)
;Isolated Mineralocorticoid deficiency-
Unilateral adrenalectomy-
DM
-Heparine therapy-
congenital-
C\P
Hypotension; due to hypovolemia*
Metabolic acidosis*
Hyperkalemia; any increase in s.*
potassium without renal impairment,
.hypoaldosteronism should be considered
hyponatremia*
Anesthetic management
;Preoperative preparation includes
correction of fluid and electrolyte*
imbalance
exogenous mineralocorticoid,*
.fludrocortison 0.1-0.3 mg\ day
Glucocorticoid excess
Cushing syndrome
:Causes
Frequency
Most cases of Cushing syndrome are due to
exogenous glucocorticoids. Endogenous
Cushing syndrome has been estimated at 13
.cases per million individuals
Age
The peak incidence of Cushing syndrome due to
either an adrenal or pituitary adenoma is in
persons aged 25-40 years
Ectopic ACTH production due to lung cancer
occurs later in life
Sex
The female-to-male incidence ratio is
approximately 5:1 for Cushing syndrome due to
an adrenal or pituitary tumor
Mortality/Morbidity
Morbidity and mortality associated with Cushing*
syndrome are related primarily to the effects of
excess glucocorticoids. However, a large primary
pituitary tumor may cause panhypopituitarism and
.visual loss
adrenocortical carcinomas are associated with a*
.5-year survival rate of 30% or less
C\p
Obesity
moon facies-
buffalo hump-
Central obesity, increased waist-to-hip ratio-
greater than 1 in men and 0.8 in women
Skin
Facial plethora
abdominal striae
lanugo facial hair
Hirsutism and Steroid acne
endocrine
Galactorrhea and menstrual disturbances
.decreased libido and impotence in men
Skeletal/muscular
Proximal muscle weakness
Osteoporosis and osteopenia
Avascular necrosis of the hip
Neuropsychological
emotional liability, fatigue, and depression
Visual-field defects, often bitemporal, and
blurred vision
Adrenal crisis
Investigations
Laboratory Studies
Hyperglycemia
Hypokalemic metabolic alkalosis
Imaging studies
CT or MRI brain and abdomen
Treatment
Hypopysectomy for pituitary tumors, or*
.adrenalectomy for adrenal tumors
Anesthetic considerations
Preoperative management
From the C\P those pt. Tend to be volume
overloaded, hypertensive and hypokalemic, so
Preoperative correction of these factors are
.essential by potassium and spironolactone
Intaoperative
Patients with osteoprosis are at risk for fracture
.during positioning
Preoperative weakness may indicate an
.increased sensitivity to muscle relaxants
Pseudo-Cushing Syndrome
In 1976, Smalls and associates described 3
alcoholic patients who had the physical and
biochemical abnormalities of Cushing syndrome.
Most of the abnormalities disappeared with 1-3
weeks of alcohol abstinence. About 30 cases
.have been reported
Pathophysiology
The mechanism remains unclear. Most evidence
suggests central stimulation of a corticotropinreleasing hormone, either at the hypothalamic or
. suprahypothalamic level
Persistence of abnormalities may lead to
complications such as hypertension, glucose
.intolerance, diabetes mellitus, and osteoporosis
The most important part of the history is the
.extent and duration of alcohol abuse
Glucocorticoid deficiency
Addison Disease
Thomas Addison first described the clinical
presentation of primary adrenocortical
insufficiency )Addison disease( in 1855 in his
classic paper, On the Constitutional and Local
.Effects of Disease of the Supra-Renal Capsules
Pathophysiology
Addison disease is adrenocortical insufficiency due
to the destruction or dysfunction of the entire
adrenal cortex. It affects glucocorticoid and
mineralocorticoid function. The onset of disease
usually occurs when 90% or more of both
.adrenal cortices are dysfunctional or destroyed
Frequency
The prevalence of Addison disease is 40-60 cases
.per 1 million population
Causes
idiopathic autoimmune adrenocortical- 1
.insufficiency
Chronic granulomatous diseases; TB,- 2
. sarcoidosis, histoplasmosis
Hematologic malignancies; as Hodgkin- 3
. and non-Hodgkin lymphoma and leukemia
Age
The most common age at presentation in adults
.is 30-50 years
Sex
Idiopathic autoimmune Addison disease tends to
.be more common in females and children
C\P
Patients usually present with features of both
glucocorticoid and mineralocorticoid deficiency.
The predominant symptoms vary depending on
.the duration of disease
Hyperpigmentation of the skin and mucous -
.membranes due to high ACTH
vitiligo, which most often is seen in idiopathic .autoimmune Addison disease
Investigations
Laboratory Studies
ACTH stimulation test; In patients with Addison-
disease, both cortisol and aldosterone show
.minimal or no change in response to ACTH
hyponatremia-
Hyperkalemia
metabolic acidosis
Imaging study
Chest x-ray TB
CT abdomen
Treatment
Anesthetic considerations
Preoperative management
ensure adequate replacement therapy*
correct fluid and electrolytes disturbaces*
Intaoperative
.ensure adequate fluid
Postoperative
Continue the stress dose of steroids to gard
.against acute adrenal crisis
Preeclampsia or pregnancy-induced
hypertension is noted in approximately 10% of
.patients
.Gestational DM occurs in approximately one third
Congestive heart failure associated with severe
.hypertension occurs in 10%